Article metrics
Other content recommended for you
- Position statement on ethics, equipoise and research on charged particle radiation therapy
- Proton beam therapy: the next disruptive innovation in healthcare?
- Local treatment failure after globe-conserving therapy for choroidal melanoma
- Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma
- Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial
- PO-109 Particle therapy reduces weight loss and toxicities among patients with head and neck cancer
- Uveal tumour resection
- Impact of tumour volume and treatment delay on the outcome after linear accelerator-based fractionated stereotactic radiosurgery of uveal melanoma
- The role of proton therapy in gynecological radiation oncology
- Proton therapy for craniopharyngioma in adults: a protocol for systematic review and meta-analysis